Molecular oncology
Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma.
Naroa Goikoetxea-Usandizaga, María Luz Martinez-Chantar, Carolina Conter
Published: 202510.1002/1878-0261.70194
Abstract
Metabolic dysfunction-associated steatohepatitis (MASH) is emerging as a major driver of hepatocellular carcinoma (HCC). Crouchet et al. identify PRDX2 as a key regulator linking oxidative stress, metabolic imbalance, and oncogenic signaling. Across…
Preview only. Read the full abstract at the source